Literature DB >> 15170226

Human BAC-mediated rescue of the Friedreich ataxia knockout mutation in transgenic mice.

Joseph P Sarsero1, Lingli Li, Timothy P Holloway, Lucille Voullaire, Sophie Gazeas, Kerry J Fowler, Denise M Kirby, David R Thorburn, Adam Galle, Surindar Cheema, Michel Koenig, Robert Williamson, Panos A Ioannou.   

Abstract

Three independent transgenic mouse lines were generated with the human Friedreich ataxia gene, FRDA, in an 188-kb bacterial artificial chromosome (BAC) genomic sequence. Three copies of the transgene per diploid mouse genome were integrated in a single site in each mouse line. Transgenic mice were mated with mice heterozygous for a knockout mutation of the murine Frda gene, to generate mice homozygous for the Frda knockout mutation and hemizygous or homozygous for the human transgene. Rescue of the embryonic lethality that is associated with homozygosity for the Frda knockout mutation was observed in all three lines. Rescued mice displayed normal behavioral and biochemical parameters. RT-PCR analysis demonstrated that human FRDA mRNA is expressed in all the lines. The relative expression of the human FRDA and mouse Frda genes showed a similar pattern in different tissues in all three lines, indicating position-independent control of expression of the human FRDA transgene. However, large differences in the human:mouse mRNA ratio were observed between different tissues in all three lines. The human transgene is expressed at much higher levels in the brain, liver, and skeletal muscle than the endogenous gene, while expression of the human transgene in blood is only 25-30% of the mouse gene. These studies will facilitate the development of humanized mouse models of Friedreich ataxia through introduction of a GAA trinucleotide expansion or specific known point mutations in the normal human FRDA locus and the study of the regulation of gene expression from the FRDA locus.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15170226     DOI: 10.1007/s00335-004-3019-3

Source DB:  PubMed          Journal:  Mamm Genome        ISSN: 0938-8990            Impact factor:   2.957


  39 in total

1.  Insertion of modifications in the beta-globin locus using GET recombination with single-stranded oligonucleotides and denatured PCR fragments.

Authors:  Duangporn Jamsai; Michael Orford; Suthat Fucharoen; Robert Williamson; Panayiotis A Ioannou
Journal:  Mol Biotechnol       Date:  2003-01       Impact factor: 2.695

2.  Targeted modification of a human beta-globin locus BAC clone using GET Recombination and an I-Scei counterselection cassette.

Authors:  Duangporn Jamsai; Michael Orford; Mikhail Nefedov; Suthat Fucharoen; Robert Williamson; Panayiotis A Ioannou
Journal:  Genomics       Date:  2003-07       Impact factor: 5.736

3.  Cloning and stable maintenance of 300-kilobase-pair fragments of human DNA in Escherichia coli using an F-factor-based vector.

Authors:  H Shizuya; B Birren; U J Kim; V Mancino; T Slepak; Y Tachiiri; M Simon
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

4.  A physical map of the human genome.

Authors:  J D McPherson; M Marra; L Hillier; R H Waterston; A Chinwalla; J Wallis; M Sekhon; K Wylie; E R Mardis; R K Wilson; R Fulton; T A Kucaba; C Wagner-McPherson; W B Barbazuk; S G Gregory; S J Humphray; L French; R S Evans; G Bethel; A Whittaker; J L Holden; O T McCann; A Dunham; C Soderlund; C E Scott; D R Bentley; G Schuler; H C Chen; W Jang; E D Green; J R Idol; V V Maduro; K T Montgomery; E Lee; A Miller; S Emerling; R Gibbs; S Scherer; J H Gorrell; E Sodergren; K Clerc-Blankenburg; P Tabor; S Naylor; D Garcia; P J de Jong; J J Catanese; N Nowak; K Osoegawa; S Qin; L Rowen; A Madan; M Dors; L Hood; B Trask; C Friedman; H Massa; V G Cheung; I R Kirsch; T Reid; R Yonescu; J Weissenbach; T Bruls; R Heilig; E Branscomb; A Olsen; N Doggett; J F Cheng; T Hawkins; R M Myers; J Shang; L Ramirez; J Schmutz; O Velasquez; K Dixon; N E Stone; D R Cox; D Haussler; W J Kent; T Furey; S Rogic; S Kennedy; S Jones; A Rosenthal; G Wen; M Schilhabel; G Gloeckner; G Nyakatura; R Siebert; B Schlegelberger; J Korenberg; X N Chen; A Fujiyama; M Hattori; A Toyoda; T Yada; H S Park; Y Sakaki; N Shimizu; S Asakawa; K Kawasaki; T Sasaki; A Shintani; A Shimizu; K Shibuya; J Kudoh; S Minoshima; J Ramser; P Seranski; C Hoff; A Poustka; R Reinhardt; H Lehrach
Journal:  Nature       Date:  2001-02-15       Impact factor: 49.962

5.  Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes.

Authors:  V Campuzano; L Montermini; Y Lutz; L Cova; C Hindelang; S Jiralerspong; Y Trottier; S J Kish; B Faucheux; P Trouillas; F J Authier; A Dürr; J L Mandel; A Vescovi; M Pandolfo; M Koenig
Journal:  Hum Mol Genet       Date:  1997-10       Impact factor: 6.150

6.  The GAA*TTC triplet repeat expanded in Friedreich's ataxia impedes transcription elongation by T7 RNA polymerase in a length and supercoil dependent manner.

Authors:  E Grabczyk; K Usdin
Journal:  Nucleic Acids Res       Date:  2000-07-15       Impact factor: 16.971

7.  Erythroid differentiation and protoporphyrin IX down-regulate frataxin expression in Friend cells: characterization of frataxin expression compared to molecules involved in iron metabolism and hemoglobinization.

Authors:  Erika M Becker; Judith M Greer; Prem Ponka; Des R Richardson
Journal:  Blood       Date:  2002-05-15       Impact factor: 22.113

8.  Iron use for haeme synthesis is under control of the yeast frataxin homologue (Yfh1).

Authors:  Emmanuel Lesuisse; Renata Santos; Berthold F Matzanke; Simon A B Knight; Jean-Michel Camadro; Andrew Dancis
Journal:  Hum Mol Genet       Date:  2003-04-15       Impact factor: 6.150

9.  Inhibition of Fe-S cluster biosynthesis decreases mitochondrial iron export: evidence that Yfh1p affects Fe-S cluster synthesis.

Authors:  Opal S Chen; Shawn Hemenway; Jerry Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-09       Impact factor: 11.205

10.  The ferroxidase activity of yeast frataxin.

Authors:  Sungjo Park; Oleksandr Gakh; Steven M Mooney; Grazia Isaya
Journal:  J Biol Chem       Date:  2002-07-30       Impact factor: 5.157

View more
  19 in total

1.  An arrayed human genomic library constructed in the PAC shuttle vector pJCPAC-Mam2 for genome-wide association studies and gene therapy.

Authors:  John Fuesler; Yasunori Nagahama; Joseph Szulewski; Joshua Mundorff; Stephanie Bireley; Jonathon S Coren
Journal:  Gene       Date:  2012-01-24       Impact factor: 3.688

2.  A transgenic mouse model engineered to investigate human brain-derived neurotrophic factor in vivo.

Authors:  Fabrice Guillemot; Italina Cerutti; Charles Auffray; Marie-Dominique Devignes
Journal:  Transgenic Res       Date:  2007-01-16       Impact factor: 2.788

3.  Evaluation of an FRDA-EGFP genomic reporter assay in transgenic mice.

Authors:  Joseph P Sarsero; Timothy P Holloway; Lingli Li; Samuel McLenachan; Kerry J Fowler; Ivan Bertoncello; Lucille Voullaire; Sophie Gazeas; Panos A Ioannou
Journal:  Mamm Genome       Date:  2005-04       Impact factor: 2.957

Review 4.  Advancements in the pathophysiology of Friedreich's Ataxia and new prospects for treatments.

Authors:  Ngolela E Babady; Nadege Carelle; Robert D Wells; Tracey A Rouault; Michio Hirano; David R Lynch; Martin B Delatycki; Robert B Wilson; Grazia Isaya; Hélène Puccio
Journal:  Mol Genet Metab       Date:  2007-06-26       Impact factor: 4.797

5.  GAA repeat expansion mutation mouse models of Friedreich ataxia exhibit oxidative stress leading to progressive neuronal and cardiac pathology.

Authors:  Sahar Al-Mahdawi; Ricardo Mouro Pinto; Dhaval Varshney; Lorraine Lawrence; Margaret B Lowrie; Sian Hughes; Zoe Webster; Julian Blake; J Mark Cooper; Rosalind King; Mark A Pook
Journal:  Genomics       Date:  2006-08-17       Impact factor: 5.736

6.  A 191-kb genomic fragment containing the human alpha-globin locus can rescue alpha-thalassemic mice.

Authors:  Keith Al-Hasani; Jim Vadolas; Anja S Knaupp; Hady Wardan; Lucille Voullaire; Robert Williamson; Panayiotis A Ioannou
Journal:  Mamm Genome       Date:  2005-11-11       Impact factor: 2.957

Review 7.  Mouse models of triplet repeat diseases.

Authors:  Gillian P Bates; Roman Gonitel
Journal:  Mol Biotechnol       Date:  2006-02       Impact factor: 2.695

8.  Epigenetic deregulation of the human Oct4 promoter in mouse cells.

Authors:  Young Cha; Min-Kyung Sung; Kyung-Won Jung; Hwan-Hee Kim; Su-Man Lee; Kyung-Soon Park
Journal:  Dev Genes Evol       Date:  2008-09-23       Impact factor: 0.900

9.  Prospects for the use of artificial chromosomes and minichromosome-like episomes in gene therapy.

Authors:  Sara Pérez-Luz; Javier Díaz-Nido
Journal:  J Biomed Biotechnol       Date:  2010-08-24

10.  The first cellular models based on frataxin missense mutations that reproduce spontaneously the defects associated with Friedreich ataxia.

Authors:  Nadège Calmels; Stéphane Schmucker; Marie Wattenhofer-Donzé; Alain Martelli; Nadège Vaucamps; Laurence Reutenauer; Nadia Messaddeq; Cécile Bouton; Michel Koenig; Hélène Puccio
Journal:  PLoS One       Date:  2009-07-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.